Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beriplex P/N in acquired coagulation factor deficiency
NCT00168077Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of balfaxar in acquired coagulation factor deficiency, sponsored by CSL Limited. Started Sep 2005; status: completed.
02
Drugs
balfaxar
03
Conditions
acquired coagulation factor deficiency
Beyond the preview
Go deeper on NCT00168077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168077.